Reneurogen LLC
ReNeuroGen LLC is a virtual pharmaceutical company based in Elm Grove, WI, specializing in developing innovative systems pharmacology therapies for neurological and pulmonary diseases. Their lead candidate, KYC, is a tripeptide myeloperoxidase inhibitor designed to treat conditions such as Sickle Cell Disease, Multiple Sclerosis, Brain Injury, and Bronchopulmonary Dysplasia.
Founded by a team of experienced leaders in the field, including Co-Founder and CEO Dr. Stephen Naylor, ReNeuroGen is dedicated to advancing personalized medicine through cutting-edge research and development efforts, with a focus on addressing complex multi-target disease states to improve patient outcomes.
Generated from the website
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.